The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-cyclopropyl-5-((2'-(N-phenylsulfamoyl)biphenyl-4-yl)methyl)-1-propyl-1H-pyrazole-4-carboxylic acid ID: ALA2283574
PubChem CID: 76327282
Max Phase: Preclinical
Molecular Formula: C29H29N3O4S
Molecular Weight: 515.64
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCn1nc(C2CC2)c(C(=O)O)c1Cc1ccc(-c2ccccc2S(=O)(=O)Nc2ccccc2)cc1
Standard InChI: InChI=1S/C29H29N3O4S/c1-2-18-32-25(27(29(33)34)28(30-32)22-16-17-22)19-20-12-14-21(15-13-20)24-10-6-7-11-26(24)37(35,36)31-23-8-4-3-5-9-23/h3-15,22,31H,2,16-19H2,1H3,(H,33,34)
Standard InChI Key: FZYDKZAAWXSXIF-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
31.6503 -19.2741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6492 -20.0937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3572 -20.5026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0669 -20.0932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0640 -19.2705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3554 -18.8653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7717 -20.4999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7716 -21.3182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4792 -21.7256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1872 -21.3159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1833 -20.4944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4752 -20.0907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9425 -18.8657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9423 -18.0485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6091 -17.5692 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.3564 -16.7921 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.5391 -16.7923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2869 -17.5696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5060 -17.8228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8993 -17.2753 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.3351 -18.6219 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.3857 -17.8236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9943 -17.2783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8264 -16.4786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4717 -19.2736 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
35.1776 -18.8619 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.6782 -19.4805 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.8887 -18.6881 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.8871 -19.2674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8870 -20.0842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5957 -20.4896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3026 -20.0779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2964 -19.2565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5872 -18.8548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0586 -16.1313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9711 -15.3234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3101 -15.8039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
4 7 1 0
1 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 14 2 0
19 20 1 0
19 21 2 0
18 19 1 0
15 22 1 0
22 23 1 0
23 24 1 0
12 25 1 0
25 26 1 0
25 27 2 0
25 28 2 0
26 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 29 1 0
17 35 1 0
36 35 1 0
37 36 1 0
35 37 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 515.64Molecular Weight (Monoisotopic): 515.1879AlogP: 5.93#Rotatable Bonds: 10Polar Surface Area: 101.29Molecular Species: ACIDHBA: 5HBD: 2#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 3.36CX Basic pKa: 1.89CX LogP: 5.51CX LogD: 2.22Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.27Np Likeness Score: -0.97
References 1. Sharma MC, Kohli DV. (2013) Comprehensive structureactivity relationship analysis of substituted 5-(biphenyl-4-ylmethyl) pyrazoles derivatives as AT1 selective angiotensin II receptor antagonists: 2D and kNNMFA QSAR approach, 22 (5): [10.1007/s00044-012-0206-8 ]